Evidence map›Paper›PMID 35628937›Full record

ArticleJournal of clinical medicine2022

Cardiovascular Profile of South African Adults with Low-Level Viremia during Antiretroviral Therapy.

Shani Botha-Le Roux, Olof Elvstam, Patrick De Boever, Nandu Goswami, Martin Magnusson, Peter M Nilsson, Hans Strijdom, Per Björkman, Carla M T Fourie

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Observational
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 4 countries.

Shani Botha-Le RouxHypertension in Africa Research Team (HART), North-West University, Potchefstroom 2520, South Africa.ORCID 0000-0001-5099-3408
Olof ElvstamDepartment of Translational Medicine, Lund University, 204 02 Malmö, Sweden.ORCID 0000-0003-3799-9869
Patrick De BoeverDepartment of Biology, University of Antwerp, 2610 Wilrijk, Belgium.ORCID 0000-0002-5197-8215
Nandu GoswamiGravitational Physiology, Aging and Medicine Research Unit, Physiology Division, Medical University of Graz, Neue Stiftingtalstrasse 6, D-5, 8010 Graz, Austria.ORCID 0000-0002-6704-0723
Martin MagnussonHypertension in Africa Research Team (HART), North-West University, Potchefstroom 2520, South Africa.ORCID 0000-0003-1710-5936
Peter M NilssonDepartment of Clinical Sciences, Lund University, 205 02 Malmö, Sweden.ORCID 0000-0002-5652-8459
Hans StrijdomCentre for Cardio-Metabolic Research in Africa, Division of Medical Physiology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town 8000, South Africa.ORCID 0000-0003-3726-9153
Per BjörkmanDepartment of Translational Medicine, Lund University, 204 02 Malmö, Sweden.ORCID 0000-0002-3697-9375
Carla M T FourieHypertension in Africa Research Team (HART), North-West University, Potchefstroom 2520, South Africa.ORCID 0000-0003-1950-1553
Lund University · SENorth-West University · ZAMedical University of Graz · ATStellenbosch University · ZAUniversity of Antwerp · BE

Funding

Belgian Science Policy, Belgium BL/67/eranet03Department of Science and Innovation, South Africa DSI/CON 0133/2016Österreichische Agentur für internationale Mobilitätund Kooperation in Bildung, Wissenschaft und Forschung, OeAD GmbH (ÖAD) in Austria KEF-Projekt P202
6 · The paper itself

Abstract

Chronic inflammation is an HIV infection feature, contributing to elevated risk of cardiovascular disease among people with HIV, which can be induced by viral replication. A proportion of antiretroviral therapy (ART) recipients fail to achieve viral suppression, despite not meeting criteria for treatment failure, so-called low-level viremia (LLV). We investigated the relationship between LLV and an array of cardiovascular measures and biomarkers. South Africans with LLV (viral load = 50−999 copies/mL) and virological suppression (viral load <50 copies/mL) were selected from the EndoAfrica study (all receiving efavirenz-based ART) for cross-sectional comparison of vascular structure and function measures, as well as 21 plasma biomarkers related to cardiovascular risk and inflammation. Associations were investigated with univariate, multivariate, and binomial logistic regression analyses (having outcome measures above (cases) or below (controls) the 75th percentile). Among 208 participants, 95 (46%) had LLV, and 113 (54%) had viral suppression. The median age was 44 years, 73% were women, and the median ART duration was 4.5 years. Cardiovascular measures and biomarker levels were similar between these two categories. Cardiovascular function and structure measures were not associated with viremia status and having LLV did not increase the odds of having outcome measures above the 75th percentile. In this study among South African ART recipients, LLV did not associate with cardiovascular risk.

Indexed as

biomarkersblood vesselscardiovascular diseasehuman immunodeficiency virusviral load

Identifiers

PMID35628937
PMCPMC9144153
OpenAlexW4280569191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.